Adenovirus serotype 26 and serotype 35 filovirus vaccines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9701718
SERIAL NO

13994532

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are recombinant adenovirus vectors (serotype 26 and serotype 35) encoding filovirus antigens. The adenovirus vectors can be used to induce protective immune responses against filovirus infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN VACCINES & PREVENTION B VARCHIMEDESWEG 4 LEIDEN 2333 CN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asiedu, Clement Olney, US 5 31
Cheng, Cheng Rockville, US 86 192
Goudsmit, Jaap Amsterdam, NL 41 552
Nabel, Gary J Washington, US 131 4161
Pau, Maria Grazia Leiden, NL 30 242
Sullivan, Nancy J Kensington, US 13 40

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00